Akari Therapeutics (NASDAQ:AKTX) Share Price Passes Above 50 Day Moving Average – Here’s What Happened

Akari Therapeutics, Plc (NASDAQ:AKTX) shares crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $1.17 and traded as high as $1.35. Akari Therapeutics shares last traded at $1.33, with a volume of 21,578 shares traded.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on shares of Akari Therapeutics in a report on Wednesday. They issued a “sell” rating on the stock.

Akari Therapeutics Price Performance

The firm’s fifty day simple moving average is $1.17 and its 200 day simple moving average is $2.44.

Akari Therapeutics Company Profile

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid, as well as pre-clinical program developing long-acting PASylated-nomacopan for treatment of geographic atrophy secondary to dry age-related macular degeneration.